Modafinil is an FDA-approved wakefulness-promoting agent originally developed to treat excessive sleepiness associated with narcolepsy. It also shows promise for off-label uses in psychiatry, including treatment-resistant depression and attention-deficit hyperactivity disorder. A number of studies have found that Modafinil improves performance on cognitive tasks, especially when subjects are not sleep deprived. These effects seem to […]